METOPROLOL AND DEBRISOQUIN METABOLISM IN NIGERIANS - LACK OF EVIDENCE FOR POLYMORPHIC OXIDATION

被引：82

作者：

IYUN, AO

LENNARD, MS

TUCKER, GT

WOODS, HF

机构：

[1] UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,DEPT THERAPEUT,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND

[2] UNIV COLL HOSP IBADAN,DEPT MED,IBADAN,NIGERIA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1986年 / 40卷 / 04期

关键词：

D O I：

10.1038/clpt.1986.195

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：387 / 394

页数：8

共 27 条

[1]

BACK D J, 1985, British Journal of Pharmacology, V86, p801P

[2]

EDOZIEN J. C., 1960, West African Medical Journal, V9, P204

[3]

EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001

[4] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[5]

GILLES H. M., 1963, BRIT MED JOUR, V5348, P27

[6]

IDLE JR, 1984, 2ND P WORLD C CLIN P

[7] DEBRISOQUINE HYDROXYLATION CAPACITY - PROBLEMS OF ASSESSMENT IN 2 POPULATIONS [J].

INABA, T ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) :218-223

[8] COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINE [J].

INABA, T ;

VINKS, A ;

OTTON, SV ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :394-399

[9] THE POLYMORPHIC 4-HYDROXYLATION OF DEBRISOQUINE IN A SAUDI-ARAB POPULATION [J].

ISLAM, SI ;

IDLE, JR ;

SMITH, RL .

XENOBIOTICA, 1980, 10 (11) :819-825

[10]

JACKSON PR, BR J CLIN PHARM

← 1 2 3 →